|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 17, 2018 ) Industry Trend Analysis
In 2012, the global autoimmune disease diagnostics market was worth around USD 11.62 billion and is predicted to reach around USD 15.11 billion by 2022, with a compound annual growth rate (CAGR) of 2.39% during the projected period. Increasing occurrence of autoimmune diseases like type 1 diabetes in infants combined with the requirement for speedy diagnostics are the major factors driving the growth of the global market. Diagnostics and research institutes around the world are attempting initiatives in defiance with governmental organizations due to growing occurrence of autoimmune diseases and subsequent increase in overall healthcare expenditure. As per the data released by the National Institutes of Health (NIH), these diseases have been graded as among the leading ten disorders directing to escalating rate of mortality among females. Technological innovations and rising rates of lab automation are expected to boost the growth of the global market. Practitioners are implementing highly developed technology with the aim of conducting various tests at the same time with quicker and more specific outcome. Reduced turnaround linked with the application of traditional illness diagnostic techniques as well as the existence of the lesser amount of standardized tests for more than 80 types of diseases are few of the defects advocating laboratories to shift in the direction of automation. Furthermore, the existence of encouraging governmental initiatives is expected to boost industry dynamics positively. Organizations like the Cooperative Study Group for Autoimmune Disease Prevention, North American Rheumatoid Arthritis Consortium, and Autoimmunity Centers of Excellence are actively involved in giving educative knowledge to healthcare professionals and patients about proper treatment as well as diagnosis. Rising awareness among patients regarding these disorders is anticipated to boost the growth of the global market. In 2013, a study was undertaken by the American Autoimmune Related Diseases Association, Inc. (AARDA) which suggests that the capability of an Americans to identify an autoimmune disease has improved by 10%. This rise can be attributed to widespread public awareness campaigns conducted by the AARDA in March 2014, like the National Awareness Campaign and Autoimmune Awareness Month.
Request for Free Sample@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54927
Type Outlook and Trend Analysis
On account of type, autoimmune diseases are categorized into systemic and localized diseases. In 2015, localized illness diagnostics ruled the global market concerning revenue. The existence of huge process volumes and higher awareness level among patients as compared to systemic are few of the factors reporting for its large market share. Conversely, systemic illness diagnostics are projected to experience top growth during the projected period owing to the adoption of encouraging government initiatives, particularly the AMP RA/SLE program for people having systemic lupus erythematosus and rheumatoid arthritis. This program is expected to render a development platform for innovative treatment and invention of publicly approachable disease-specific and precompetitive database for more research application.
Regional Outlook and Trend Analysis
In 2015, North America regional market held the leading market share of around 40.0%, mostly owing to the initiation of the existence of positive regulations & initiatives attempted by the AARDA, elevated disease occurrence in this region and Affordable Care Act. As per the AARDA, almost 50 million people in America have some form of autoimmune disorder. An elevated occurrence of these diseases together with medical spending has actuated the launching of supportive initiatives by the governmental authorities and other market-friendly organizations. These encouraging initiatives intend to reduce medical expenditure by diagnosing the illness at a much earlier stage and escalating awareness levels of patients. Asia Pacific regional market is anticipated to experience lucrative expansion owing to continuously amending medical infrastructure, rising awareness levels among patients, and the existence of high unfulfilled patient demands. It is anticipated to witness a rise in revenue share over the forecast years. Its industry share is expected to expand from 21.0% to 22.0% over the period of 2015 to 2025.
Competitive Outlook and Trend Analysis
The market is amalgamated in nature, hence is noted by the existence of wide mergers and acquisitions. Some major participants of the global autoimmune disease diagnostics market are; Siemens Healthineers, F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., Abbott Laboratories, Quest Diagnostics, SQI Diagnostics, AESKU.Diagnostics GmbH & Co. KG, EUROIMMUN AG, INOVA Diagnostics, Inc., bioMerieux SA, Crescendo Bioscience, Inc., Hemagen Diagnostics, Inc., and Bio-Rad Laboratories, Inc. Novel products development for rapid and efficient diagnosis is major strategy attempted by most of the key industry participants. For example, during 2016, Inova Diagnostics declared the sanction of its Scl-70 assays, Jo-1 range of assays, and QUANTA Flash dsDNA for the diagnosis of systemic sclerosis, polymyositis & dermatomyositis, and systemic lupus erythematosus respectively.
Enquiry Before Buy@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54927
The global autoimmune disease diagnostics market is segmented as follows :
By Type
Systemic Autoimmune Disease Diagnostics
AnkylosingPondylitis
Rheumatoid Arthritis
Systemic Lupus Erythematosus (SLE)
Other Systemic Autoimmune Disease Diagnostics
Localized Autoimmune Disease Diagnostics
Type 1 Diabetes
Multiple Sclerosis
Idiopathic Thrombocytopenic Purpura
Hashimoto & Thyroiditis
Other Localized Autoimmune Disease Diagnostics
By Region:
North America
U.S
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
Rest of the World
Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others
Some of the key questions answered by the report are:
What was the market size in 2012 and forecast from 2013 to 2022?
What will be the industry market growth from 2013 to 2022?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Enquiry for Discount@ https://www.qurateresearch.com/report/discount/HnM/QBI-CMR-HnM-54927
Qurate Business Intelligence
Nehal Chinoy
+919881074592
nehal@qurateresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
